|
|
|
|
| LEADER |
01190nam a2200301 i 4500 |
| 001 |
NSK01000902602 |
| 003 |
HR-ZaNSK |
| 005 |
20150611155246.0 |
| 007 |
ta |
| 008 |
150325s2004 xxuad 001 0 eng |
| 020 |
|
|
|a 0824722280
|q (M. Dekker)
|
| 020 |
|
|
|a 0932763015
|q (Summit Communications)
|
| 035 |
|
|
|a (HR-ZaNSK)000902602
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 080 |
1 |
|
|a 618.19-006-085
|2 MRF 2011.
|
| 080 |
1 |
|
|a 615.2:618.19-006
|2 MRF 2011.
|
| 080 |
1 |
|
|a 577.175.6:618.19-006
|2 MRF 2011.
|
| 080 |
1 |
|
|a (062)
|2 MRF 2011.
|
| 245 |
0 |
0 |
|a Advances in endocrine therapy of breast cancer :
|b proceedings of the 2003 Gleneagles conference /
|c edited by James N. Igle, Mitchell Dowsett.
|
| 260 |
|
|
|a New York :
|b M. Dekker ;
|a [s. l.] :
|b Summit Communications,
|c cop. 2004.
|
| 300 |
|
|
|a XV, 317 str. :
|b ilustr. (djelomice u bojama), graf.prikazi (djelomice u bojama) ;
|c 24 cm.
|
| 504 |
|
|
|a Bibliografija uz svaki rad.
|
| 504 |
|
|
|a Kazalo.
|
| 650 |
|
7 |
|a Dojka
|x Karcinom
|x Endokrini aspekti
|v Kongresi
|2 nskps
|
| 650 |
|
7 |
|a Estrogeni
|x Antagonisti
|x Terapijska primjena
|v Kongresi
|2 nskps
|
| 700 |
1 |
|
|a Ingle, James N.
|4 edt
|
| 700 |
1 |
|
|a Dowsett, Mitchell
|4 edt
|
| 998 |
|
|
|m vhok1504
|c ktuo150611
|
